Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANRS 1207: TDF+FTC+EFV in HIV-1 Naive Patients
NCT00158457Phase 3Completed
- Sponsor
- ANRS
- Start
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tenofovir disoproxil fumarate, emtricitabine and efavirenz in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Primary endpoint: Percentage of patients with viral load below 400 copies/ml at 48 weeks. Started Jun 2004; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabineefavirenz
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00158457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00158457.